Skip to content

Evidence Hub

Publication
Feb 14, 2023

Incorporating linked healthcare claims to improve confounding control in a study of in-hospital medication use

Introduction The Premier Perspective hospital billing database provides a promising data ...
Start Reading
Publication
Feb 14, 2023

Empirical assessment of case‐based methods for drug safety alert identification in the French National Healthcare System database (SNDS): Methodology of the ALCAPONE project

Objectives To introduce the methodology of the ALCAPONE project. Background The French ...
Start Reading
Publication
Feb 14, 2023

Cardiovascular and Renal Outcomes in Patients with Type-2 Diabetes and Chronic Kidney Disease Identified in a United States Administrative Claims Database: A Population Cohort Study

Introduction: CKD, a common complication of type-2 diabetes (T2D), causes considerable ...
Start Reading
Publication
Feb 14, 2023

Real‐world evidence on bariatric surgery and cardiovascular benefits using electronic health record data: A lesson in bias

Aim To reproduce and correct studies on bariatric surgery and the reduction in major ...
Start Reading
Publication
Feb 14, 2023

Use of systemic immunomodulating medications in pregnant women with atopic dermatitis: a nationwide US study

No abstract available
Start Reading
Publication
Feb 14, 2023

Transparency and reproducibility of observational cohort studies using large healthcare databases.

The scientific community and decision-makers are increasingly concerned about ...
Start Reading
Publication
Feb 14, 2023

Healthcare resource utilization, costs and treatment associated with myasthenia gravis exacerbations among patients with myasthenia gravis in the US: A retrospective analysis of claims data

No Link
Start Reading
Publication
Feb 14, 2023

Visualizations throughout pharmacoepidemiology study planning, implementation, and reporting

Transparency is increasingly promoted to instill trust in nonrandomized studies using ...
Start Reading
Publication
Feb 14, 2023

Durability of the Single-Dose Ad26.COV2.S Vaccine in the Prevention of COVID-19 Infections and Hospitalizations in the US Before and During the Delta Variant Surge

Importance Vaccination against the SARS-CoV-2 virus is critical to control the pandemic. ...
Start Reading
Publication
Feb 14, 2023

Empirical assessment of case‐based methods for identification of drugs associated with acute liver injury in the French National Healthcare System database (SNDS)

Purposes Drug induced acute liver injury (ALI) is a frequent cause of liver failure. ...
Start Reading
Publication
Feb 14, 2023

Post-Authorization Safety Studies of Medicinal Products: The PASS, Chapter 3.4 Big Data

Post-Authorization Safety Studies of Medicinal Products: The PASS Book bridges the gap in ...
Start Reading
Publication
Feb 14, 2023

Association of remdesivir with lower mortality in hospitalized adults with Covid-19 in the United States

Importance SARS-CoV-2, which causes COVID-19, poses considerable morbidity and mortality ...
Start Reading
Publication
Feb 14, 2023

Opioid dispensing patterns after oocyte retrieval

Objective: To study opioid dispensing patterns following oocyte retrieval. Design: ...
Start Reading
Publication
Feb 14, 2023

Incidence of lower extremity amputations among patients with type 1 and type 2 diabetes in the United States from 2010 to 2014

Aim To compare the incidence of lower extremity amputation (LEA) among patients with type ...
Start Reading
Publication
Feb 14, 2023

Cardiovascular Burden of Narcolepsy Disease (CV-BOND): a real-world evidence study.

Study Objectives Narcolepsy is associated with cardiovascular risk factors; however, the ...
Start Reading
Publication
Feb 14, 2023

Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection

Importance Understanding the effect of serum antibodies to severe acute respiratory ...
Start Reading
Publication
Feb 14, 2023

Chronic kidney disease progression among patients with type 2 diabetes identified in US administrative claims: a population cohort study

Background Chronic kidney disease (CKD), one of the most common complications of type 2 ...
Start Reading
Publication
Feb 14, 2023

Renin-Angiotensin-Aldosterone-System inhibitor use in patients with COVID-19 infection and prevention of serious events: a cohort study in commercially insured patients in the US

Objectives There is lack of clarity regarding the role of angiotensin receptor blockers ...
Start Reading
Publication
Feb 14, 2023

Learning from the past to advance tomorrow's real world evidence: what demonstration projects have to teach us.

Regulators, health technology assessment (HTA) agencies, and payers are actively ...
Start Reading
Publication
Feb 14, 2023

A Descriptive Cohort Study of Drug Utilization Patterns Among Patients Hospitalized With Coronavirus Disease 2019 in the United States, January 2021–February 2022

Background There is a dearth of drug utilization studies for coronavirus disease 2019 ...
Start Reading
Publication
Feb 14, 2023

Healthcare Resource Utilization and Baseline Characteristics of Patients With Generalized Pustular Psoriasis: Real-World Results From a Large US Database of Multiple Commercial Medical Insurers

Background: Generalized pustular psoriasis (GPP) is a rare, severe neutrophilic skin ...
Start Reading
Publication
Feb 14, 2023

Clinical Burden of Concomitant Joint Disease in Psoriasis: A US-Linked Claims and Electronic Health Records Database Analysis

Background Few studies have evaluated the clinical burden of concomitant joint disease in ...
Start Reading
Publication
Feb 14, 2023

Clinical characteristics and healthcare resource utilization in patients with generalized pustular psoriasis: real-world evidence from a large claims-based dataset

Background: Generalized pustular psoriasis (GPP) is a rare, severe neutrophilic skin ...
Start Reading
Publication
Feb 14, 2023

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms

INTRODUCTION The emergence of three lethal coronaviruses in <20 years and the urgency ...
Start Reading